365 related articles for article (PubMed ID: 16001122)
1. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
Ball KT; Budreau D; Rebec GV
Brain Res; 2003 Dec; 994(2):203-15. PubMed ID: 14642646
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
Bishop C; Daut GS; Walker PD
Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
[TBL] [Abstract][Full Text] [Related]
5. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
6. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; De Deurwaerdére P; Di Mascio M; Di Matteo V; Esposito E; Spampinato U
Neuroscience; 1999; 91(2):587-97. PubMed ID: 10366016
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
Bankson MG; Yamamoto BK
J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
[TBL] [Abstract][Full Text] [Related]
8. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
Egerton A; Ahmad R; Hirani E; Grasby PM
Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
[TBL] [Abstract][Full Text] [Related]
9. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
Lucas G; Spampinato U
J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
11. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
12. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
14. Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.
Filip M; Bubar MJ; Cunningham KA
Psychopharmacology (Berl); 2006 Jan; 183(4):482-9. PubMed ID: 16261316
[TBL] [Abstract][Full Text] [Related]
15. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
[TBL] [Abstract][Full Text] [Related]
16. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
Broderick PA; Olabisi OA; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
[TBL] [Abstract][Full Text] [Related]
18. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
19. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
Schmidt CJ; Sullivan CK; Fadayel GM
J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
[TBL] [Abstract][Full Text] [Related]
20. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]